Annual Net Income
-$26.08 M
-$46.37 M-228.54%
01 July 2024
Summary:
Enzo Biochem annual net profit is currently -$26.08 million, with the most recent change of -$46.37 million (-228.54%) on 01 July 2024. During the last 3 years, it has fallen by -$33.95 million (-431.15%). ENZ annual net income is now -157.59% below its all-time high of $45.29 million, reached on 31 July 2016.ENZ Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$13.38 M
-$10.36 M-343.08%
01 July 2024
Summary:
Enzo Biochem quarterly net profit is currently -$13.38 million, with the most recent change of -$10.36 million (-343.08%) on 01 July 2024. Over the past year, it has dropped by -$6.76 million (-102.25%). ENZ quarterly net income is now -123.30% below its all-time high of $57.43 million, reached on 31 July 2023.ENZ Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$26.08 M
-$70.81 M-158.30%
01 July 2024
Summary:
Enzo Biochem TTM net profit is currently -$26.08 million, with the most recent change of -$70.81 million (-158.30%) on 01 July 2024. Over the past year, it has dropped by -$50.38 million (-207.29%). ENZ TTM net income is now -157.59% below its all-time high of $45.29 million, reached on 31 July 2016.ENZ TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENZ Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -228.5% | -102.3% | -207.3% |
| 3 y3 years | -431.1% | -477.0% | -596.1% |
| 5 y5 years | -1147.7% | -75.0% | -3272.5% |
ENZ Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -228.5% | at low | -123.3% | +11.9% | -158.3% | +42.8% |
| 5 y | 5 years | -228.5% | +8.6% | -123.3% | +11.9% | -158.3% | +42.8% |
| alltime | all time | -157.6% | +33.6% | -123.3% | +50.7% | -157.6% | +42.8% |
Enzo Biochem Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| July 2024 | -$26.08 M(-228.5%) | -$13.38 M(+343.1%) | -$26.08 M(-158.3%) |
| Apr 2024 | - | -$3.02 M(-1.3%) | $44.73 M(+37.4%) |
| Jan 2024 | - | -$3.06 M(-53.7%) | $32.57 M(+34.0%) |
| Oct 2023 | - | -$6.62 M(-111.5%) | $24.31 M(+19.8%) |
| July 2023 | $20.29 M(-211.1%) | $57.43 M(-478.2%) | $20.29 M(-144.5%) |
| Apr 2023 | - | -$15.19 M(+34.2%) | -$45.58 M(+29.3%) |
| Jan 2023 | - | -$11.32 M(+6.4%) | -$35.24 M(+32.6%) |
| Oct 2022 | - | -$10.63 M(+26.1%) | -$26.58 M(+45.5%) |
| July 2022 | -$18.26 M(-331.9%) | -$8.43 M(+73.7%) | -$18.26 M(+178.4%) |
| Apr 2022 | - | -$4.85 M(+82.8%) | -$6.56 M(-2286.7%) |
| Jan 2022 | - | -$2.65 M(+14.5%) | $300.00 K(-94.3%) |
| Oct 2021 | - | -$2.32 M(-171.0%) | $5.26 M(-33.2%) |
| July 2021 | $7.88 M(-127.6%) | $3.27 M(+62.9%) | $7.88 M(+514.3%) |
| Apr 2021 | - | $2.01 M(-12.9%) | $1.28 M(-112.1%) |
| Jan 2021 | - | $2.30 M(+669.9%) | -$10.58 M(-48.6%) |
| Oct 2020 | - | $299.00 K(-109.0%) | -$20.57 M(-27.9%) |
| July 2020 | -$28.52 M(-1245.8%) | -$3.33 M(-66.3%) | -$28.52 M(-6.7%) |
| Apr 2020 | - | -$9.86 M(+28.3%) | -$30.58 M(-2082.0%) |
| Jan 2020 | - | -$7.69 M(+0.5%) | $1.54 M(+87.7%) |
| Oct 2019 | - | -$7.65 M(+42.0%) | $822.00 K(-67.0%) |
| July 2019 | $2.49 M(-124.1%) | -$5.39 M(-124.2%) | $2.49 M(+17.9%) |
| Apr 2019 | - | $22.27 M(-364.8%) | $2.11 M(-109.1%) |
| Jan 2019 | - | -$8.41 M(+40.6%) | -$23.17 M(+47.9%) |
| Oct 2018 | - | -$5.98 M(+3.8%) | -$15.66 M(+51.7%) |
| July 2018 | -$10.32 M(+312.2%) | -$5.76 M(+91.1%) | -$10.32 M(+131.3%) |
| Apr 2018 | - | -$3.02 M(+234.7%) | -$4.46 M(+194.0%) |
| Jan 2018 | - | -$901.00 K(+40.8%) | -$1.52 M(-9.1%) |
| Oct 2017 | - | -$640.00 K(-780.9%) | -$1.67 M(-33.3%) |
| July 2017 | -$2.50 M(-105.5%) | $94.00 K(-232.4%) | -$2.50 M(-107.5%) |
| Apr 2017 | - | -$71.00 K(-93.3%) | $33.54 M(+6.5%) |
| Jan 2017 | - | -$1.05 M(-28.6%) | $31.49 M(-20.0%) |
| Oct 2016 | - | -$1.47 M(-104.1%) | $39.38 M(-13.0%) |
| July 2016 | $45.29 M(-2081.9%) | $36.13 M(-1808.5%) | $45.29 M(+157.4%) |
| Apr 2016 | - | -$2.12 M(-131.0%) | $17.59 M(+4.7%) |
| Jan 2016 | - | $6.83 M(+54.1%) | $16.80 M(+185.8%) |
| Oct 2015 | - | $4.43 M(-47.5%) | $5.88 M(-357.2%) |
| July 2015 | -$2.29 M(-77.1%) | $8.44 M(-390.4%) | -$2.29 M(-83.6%) |
| Apr 2015 | - | -$2.91 M(-28.9%) | -$13.90 M(+21.4%) |
| Jan 2015 | - | -$4.09 M(+9.7%) | -$11.44 M(+4.8%) |
| Oct 2014 | - | -$3.73 M(+17.7%) | -$10.92 M(+9.4%) |
| July 2014 | -$9.98 M(-45.3%) | -$3.17 M(+596.5%) | -$9.98 M(+0.7%) |
| Apr 2014 | - | -$455.00 K(-87.2%) | -$9.91 M(-34.9%) |
| Jan 2014 | - | -$3.57 M(+28.0%) | -$15.22 M(-12.2%) |
| Oct 2013 | - | -$2.79 M(-10.2%) | -$17.33 M(-5.0%) |
| July 2013 | -$18.24 M(-53.6%) | -$3.10 M(-46.2%) | -$18.24 M(-56.9%) |
| Apr 2013 | - | -$5.77 M(+1.7%) | -$42.28 M(+5.9%) |
| Jan 2013 | - | -$5.67 M(+53.7%) | -$39.92 M(+3.8%) |
| Oct 2012 | - | -$3.69 M(-86.4%) | -$38.47 M(-2.0%) |
| July 2012 | -$39.27 M(+203.0%) | -$27.14 M(+695.7%) | -$39.27 M(+143.2%) |
| Apr 2012 | - | -$3.41 M(-19.2%) | -$16.15 M(+8.8%) |
| Jan 2012 | - | -$4.22 M(-6.1%) | -$14.85 M(-9.1%) |
| Oct 2011 | - | -$4.49 M(+11.7%) | -$16.34 M(+26.0%) |
| July 2011 | -$12.96 M(-41.7%) | -$4.02 M(+90.7%) | -$12.96 M(-10.3%) |
| Apr 2011 | - | -$2.11 M(-63.0%) | -$14.45 M(-14.6%) |
| Jan 2011 | - | -$5.71 M(+408.7%) | -$16.92 M(-21.4%) |
| Oct 2010 | - | -$1.12 M(-79.6%) | -$21.54 M(-3.1%) |
| July 2010 | -$22.23 M(-5.6%) | -$5.51 M(+20.5%) | -$22.23 M(+1.1%) |
| Apr 2010 | - | -$4.58 M(-55.7%) | -$22.00 M(+1.5%) |
| Jan 2010 | - | -$10.33 M(+469.3%) | -$21.66 M(+14.0%) |
| Oct 2009 | - | -$1.81 M(-65.6%) | -$19.01 M(-19.3%) |
| July 2009 | -$23.56 M(+121.2%) | -$5.28 M(+24.4%) | -$23.56 M(+9.4%) |
| Apr 2009 | - | -$4.24 M(-44.7%) | -$21.54 M(+11.0%) |
| Jan 2009 | - | -$7.67 M(+20.5%) | -$19.41 M(+22.9%) |
| Oct 2008 | - | -$6.37 M(+95.5%) | -$15.79 M(+48.2%) |
| July 2008 | -$10.65 M(-19.7%) | -$3.26 M(+54.6%) | -$10.65 M(-0.7%) |
| Apr 2008 | - | -$2.11 M(-48.0%) | -$10.72 M(-13.9%) |
| Jan 2008 | - | -$4.05 M(+229.0%) | -$12.45 M(-6.0%) |
| Oct 2007 | - | -$1.23 M(-63.0%) | -$13.25 M(-0.1%) |
| July 2007 | -$13.26 M(-15.4%) | -$3.33 M(-13.1%) | -$13.26 M(-8.2%) |
| Apr 2007 | - | -$3.83 M(-21.0%) | -$14.44 M(+2.8%) |
| Jan 2007 | - | -$4.85 M(+289.4%) | -$14.04 M(+3.0%) |
| Oct 2006 | - | -$1.25 M(-72.4%) | -$13.63 M(-13.0%) |
| July 2006 | -$15.67 M(-621.5%) | -$4.51 M(+31.2%) | -$15.67 M(+19.1%) |
| Apr 2006 | - | -$3.44 M(-22.6%) | -$13.15 M(+17.3%) |
| Jan 2006 | - | -$4.44 M(+35.1%) | -$11.21 M(+53.6%) |
| Oct 2005 | - | -$3.29 M(+65.0%) | -$7.30 M(-343.0%) |
| July 2005 | $3.00 M(-148.2%) | -$1.99 M(+33.0%) | $3.00 M(+199.6%) |
| Apr 2005 | - | -$1.50 M(+183.5%) | $1.00 M(-50.8%) |
| Jan 2005 | - | -$528.00 K(-107.5%) | $2.04 M(+83.3%) |
| Oct 2004 | - | $7.02 M(-275.8%) | $1.11 M(-117.9%) |
| July 2004 | -$6.23 M | -$3.99 M(+768.0%) | -$6.23 M(+30.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Apr 2004 | - | -$460.00 K(-68.4%) | -$4.76 M(+55.2%) |
| Jan 2004 | - | -$1.46 M(+350.5%) | -$3.07 M(+1737.1%) |
| Oct 2003 | - | -$323.00 K(-87.2%) | -$167.00 K(-104.3%) |
| July 2003 | $3.84 M(-44.5%) | -$2.52 M(-304.6%) | $3.84 M(-52.5%) |
| Apr 2003 | - | $1.23 M(-14.7%) | $8.09 M(-14.0%) |
| Jan 2003 | - | $1.45 M(-60.8%) | $9.41 M(+7.1%) |
| Oct 2002 | - | $3.69 M(+113.8%) | $8.79 M(+26.9%) |
| July 2002 | $6.92 M(+1.6%) | $1.72 M(-32.4%) | $6.92 M(+0.2%) |
| Apr 2002 | - | $2.55 M(+210.3%) | $6.91 M(+11.1%) |
| Jan 2002 | - | $822.00 K(-55.0%) | $6.22 M(-10.7%) |
| Oct 2001 | - | $1.82 M(+6.5%) | $6.96 M(+2.2%) |
| July 2001 | $6.81 M(+2.8%) | $1.71 M(-7.9%) | $6.81 M(+1.9%) |
| Apr 2001 | - | $1.86 M(+18.9%) | $6.68 M(-2.1%) |
| Jan 2001 | - | $1.56 M(-6.5%) | $6.83 M(+1.0%) |
| Oct 2000 | - | $1.67 M(+5.6%) | $6.76 M(+2.6%) |
| July 2000 | $6.62 M(+1.9%) | $1.58 M(-20.9%) | $6.59 M(-15.6%) |
| Apr 2000 | - | $2.00 M(+33.5%) | $7.80 M(+4.0%) |
| Jan 2000 | - | $1.50 M(0.0%) | $7.50 M(+2.7%) |
| Oct 1999 | - | $1.50 M(-46.4%) | $7.30 M(+12.3%) |
| July 1999 | $6.50 M(+91.2%) | $2.80 M(+64.7%) | $6.50 M(+27.5%) |
| Apr 1999 | - | $1.70 M(+30.8%) | $5.10 M(+18.6%) |
| Jan 1999 | - | $1.30 M(+85.7%) | $4.30 M(+19.4%) |
| Oct 1998 | - | $700.00 K(-50.0%) | $3.60 M(+5.9%) |
| July 1998 | $3.40 M(+126.7%) | $1.40 M(+55.6%) | $3.40 M(+30.8%) |
| Apr 1998 | - | $900.00 K(+50.0%) | $2.60 M(+13.0%) |
| Jan 1998 | - | $600.00 K(+20.0%) | $2.30 M(+21.1%) |
| Oct 1997 | - | $500.00 K(-16.7%) | $1.90 M(+26.7%) |
| July 1997 | $1.50 M(-119.5%) | $600.00 K(0.0%) | $1.50 M(-117.2%) |
| Apr 1997 | - | $600.00 K(+200.0%) | -$8.70 M(-2.2%) |
| Jan 1997 | - | $200.00 K(+100.0%) | -$8.90 M(+4.7%) |
| Oct 1996 | - | $100.00 K(-101.0%) | -$8.50 M(+10.4%) |
| July 1996 | -$7.70 M(-237.5%) | -$9.60 M(-2500.0%) | -$7.70 M(-35.8%) |
| Apr 1996 | - | $400.00 K(-33.3%) | -$12.00 M(-1.6%) |
| Jan 1996 | - | $600.00 K(-33.3%) | -$12.20 M(-0.8%) |
| Oct 1995 | - | $900.00 K(-106.5%) | -$12.30 M(-319.6%) |
| July 1995 | $5.60 M(+5.7%) | -$13.90 M(-7050.0%) | $5.60 M(-77.3%) |
| Apr 1995 | - | $200.00 K(-60.0%) | $24.70 M(+1.2%) |
| Jan 1995 | - | $500.00 K(-97.3%) | $24.40 M(+3.4%) |
| Oct 1994 | - | $18.80 M(+261.5%) | $23.60 M(+345.3%) |
| July 1994 | $5.30 M(-176.8%) | $5.20 M(-5300.0%) | $5.30 M(-177.9%) |
| Apr 1994 | - | -$100.00 K(-66.7%) | -$6.80 M(-2.9%) |
| Jan 1994 | - | -$300.00 K(-160.0%) | -$7.00 M(+6.1%) |
| Oct 1993 | - | $500.00 K(-107.2%) | -$6.60 M(-1.5%) |
| July 1993 | -$6.90 M(+1050.0%) | -$6.90 M(+2200.0%) | -$6.70 M(+570.0%) |
| Apr 1993 | - | -$300.00 K(-400.0%) | -$1.00 M(+66.7%) |
| Jan 1993 | - | $100.00 K(-75.0%) | -$600.00 K(-40.0%) |
| Oct 1992 | - | $400.00 K(-133.3%) | -$1.00 M(-44.4%) |
| July 1992 | -$600.00 K(-94.4%) | -$1.20 M(-1300.0%) | -$1.80 M(-71.9%) |
| Apr 1992 | - | $100.00 K(-133.3%) | -$6.40 M(-25.6%) |
| Jan 1992 | - | -$300.00 K(-25.0%) | -$8.60 M(-15.7%) |
| Oct 1991 | - | -$400.00 K(-93.1%) | -$10.20 M(-5.6%) |
| July 1991 | -$10.80 M(+163.4%) | -$5.80 M(+176.2%) | -$10.80 M(+100.0%) |
| Apr 1991 | - | -$2.10 M(+10.5%) | -$5.40 M(+14.9%) |
| Jan 1991 | - | -$1.90 M(+90.0%) | -$4.70 M(+9.3%) |
| Oct 1990 | - | -$1.00 M(+150.0%) | -$4.30 M(+4.9%) |
| July 1990 | -$4.10 M(0.0%) | -$400.00 K(-71.4%) | -$4.10 M(-14.6%) |
| Apr 1990 | - | -$1.40 M(-6.7%) | -$4.80 M(+9.1%) |
| Jan 1990 | - | -$1.50 M(+87.5%) | -$4.40 M(+10.0%) |
| Oct 1989 | - | -$800.00 K(-27.3%) | -$4.00 M(-4.8%) |
| July 1989 | -$4.10 M(+17.1%) | -$1.10 M(+10.0%) | -$4.20 M(-4.5%) |
| Apr 1989 | - | -$1.00 M(-9.1%) | -$4.40 M(+2.3%) |
| Jan 1989 | - | -$1.10 M(+10.0%) | -$4.30 M(+10.3%) |
| Oct 1988 | - | -$1.00 M(-23.1%) | -$3.90 M(+5.4%) |
| July 1988 | -$3.50 M(+118.8%) | -$1.30 M(+44.4%) | -$3.70 M(-21.3%) |
| Apr 1988 | - | -$900.00 K(+28.6%) | -$4.70 M(+27.0%) |
| Jan 1988 | - | -$700.00 K(-12.5%) | -$3.70 M(+27.6%) |
| Oct 1987 | - | -$800.00 K(-65.2%) | -$2.90 M(+70.6%) |
| July 1987 | -$1.60 M(-206.7%) | -$2.30 M(-2400.0%) | -$1.70 M(-270.0%) |
| Apr 1987 | - | $100.00 K(0.0%) | $1.00 M(-23.1%) |
| Jan 1987 | - | $100.00 K(-75.0%) | $1.30 M(-18.8%) |
| Oct 1986 | - | $400.00 K(0.0%) | $1.60 M(0.0%) |
| July 1986 | $1.50 M(+15.4%) | $400.00 K(0.0%) | $1.60 M(+14.3%) |
| Apr 1986 | - | $400.00 K(0.0%) | $1.40 M(-6.7%) |
| Jan 1986 | - | $400.00 K(0.0%) | $1.50 M(+7.1%) |
| Oct 1985 | - | $400.00 K(+100.0%) | $1.40 M(+7.7%) |
| July 1985 | $1.30 M(0.0%) | $200.00 K(-60.0%) | $1.30 M(0.0%) |
| Apr 1985 | - | $500.00 K(+66.7%) | $1.30 M(+8.3%) |
| Jan 1985 | - | $300.00 K(0.0%) | $1.20 M(0.0%) |
| Oct 1984 | - | $300.00 K(+50.0%) | $1.20 M(+33.3%) |
| July 1984 | $1.30 M | $200.00 K(-50.0%) | $900.00 K(+28.6%) |
| Apr 1984 | - | $400.00 K(+33.3%) | $700.00 K(+133.3%) |
| Jan 1984 | - | $300.00 K | $300.00 K |
FAQ
- What is Enzo Biochem annual net profit?
- What is the all time high annual net income for Enzo Biochem?
- What is Enzo Biochem annual net income year-on-year change?
- What is Enzo Biochem quarterly net profit?
- What is the all time high quarterly net income for Enzo Biochem?
- What is Enzo Biochem quarterly net income year-on-year change?
- What is Enzo Biochem TTM net profit?
- What is the all time high TTM net income for Enzo Biochem?
- What is Enzo Biochem TTM net income year-on-year change?
What is Enzo Biochem annual net profit?
The current annual net income of ENZ is -$26.08 M
What is the all time high annual net income for Enzo Biochem?
Enzo Biochem all-time high annual net profit is $45.29 M
What is Enzo Biochem annual net income year-on-year change?
Over the past year, ENZ annual net profit has changed by -$46.37 M (-228.54%)
What is Enzo Biochem quarterly net profit?
The current quarterly net income of ENZ is -$13.38 M
What is the all time high quarterly net income for Enzo Biochem?
Enzo Biochem all-time high quarterly net profit is $57.43 M
What is Enzo Biochem quarterly net income year-on-year change?
Over the past year, ENZ quarterly net profit has changed by -$6.76 M (-102.25%)
What is Enzo Biochem TTM net profit?
The current TTM net income of ENZ is -$26.08 M
What is the all time high TTM net income for Enzo Biochem?
Enzo Biochem all-time high TTM net profit is $45.29 M
What is Enzo Biochem TTM net income year-on-year change?
Over the past year, ENZ TTM net profit has changed by -$50.38 M (-207.29%)